Sergio Fallone de Andrade is a senior researcher and Professor in Pharmaceutical Sciences at the Faculty of Pharmacy of the University of Lisbon, Portugal, and an integrated member of the iMed – Research Institute for Medicines. He has an academic and scientific career developed across national and international institutional contexts. He holds a Bachelor’s degree in Pharmacy from the University of Alfenas (1998), a Master’s degree in Pharmacology from São Paulo State University (2001), and a PhD in Pharmaceutical Sciences from the University of São Paulo (2005), Brazil, reflecting a solid and progressive academic background fully aligned with advanced biomedical and pharmaceutical research. His career is characterized by the consistent integration of fundamental and translational research, with a strong focus on experimental pharmacology applied to inflammation, metabolism, gastrointestinal diseases, and cancer. His research strategy combines mechanistic, cellular, and functional in vivo approaches, particularly in the pharmacological evaluation of natural products and probiotic formulations. Core research interests include gastritis, antiulcer activity, gastroprotection, hepatoprotective effects, inflammatory bowel diseases, and, more recently, tumor–immunity interactions in colorectal cancer. He has authored over 140 peer-reviewed articles in international journals, Scopus h-index of 35, contributed to five book chapters, and supervised more than 40 trainees across PhD, Master’s, undergraduate, and postdoctoral levels, evidencing strong capacity in advanced human resources training and consolidation of independent research lines. He has served four times as a guest editor for international journals and currently acts as editor for Frontiers in Pharmacology and Therapeutic Advances in Gastroenterology. Internationalization has been a defining component of his career. Between 2017 and 2018, he was a postdoctoral fellow and visiting researcher at the Faculty of Medicine, Lund University, Sweden, where he strengthened expertise in biomedical research within a clinical–experimental framework and consolidated long-term international collaborations. In July–August 2023, he served as a visiting researcher at Probi (Sweden), gaining direct exposure to applied research, innovation pipelines, and knowledge transfer in probiotics and gastrointestinal health within an industrial setting. More recently, he completed a research internship at the Lund University Advanced Cancer Centre (LUACC), where he deepened his expertise in extracellular vesicles and tumor–immune system interactions in colorectal cancer. This experience expanded his methodological portfolio and reinforced the translational and interdisciplinary dimension of his research. Sergio Fallone de Andrade holds a bachelor's degree in Pharmacy from the University of Alfenas (1998), a Master's degree in Pharmacology from São Paulo State University (2001), and a PhD in Pharmaceutical Sciences from the University of São Paulo (USP) (2005), Brazil. He completed postdoctoral fellowship at Lund University, Sweden (2017–2018). Currently, he is a Professor at the Faculty of Pharmacy of the University of Lisbon, Portugal. He has teaching and research experience, focusing on the pharmacological evaluation of natural products and probiotic formulations in vivo. His research interests include gastritis, antiulcer activity, gastroprotection, hepatoprotective effects, and inflammatory bowel diseases. Throughout his career, he supervised over 40 students, including PhD, Master´s, Undergraduate students, and postdoctoral fellow researchers. He has published over 130 articles in international journals, contributed to 5 book chapters, and served as a guest editor for international journals four times. Besides, he is an editor for "Frontiers in Pharmacology" and "Therapeutic Advances in Gastroenterology".